| scholarly article | Q13442814 |
| P50 | author | José M López-Novoa | Q39759495 |
| Carmelo Bernabeu | Q40038364 | ||
| P2093 | author name string | Chenggang Li | |
| Ian N Hampson | |||
| Shant Kumar | |||
| Pat Kumar | |||
| Razao Issa | |||
| P433 | issue | Pt 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| endothelium | Q111140 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 2677-2685 | |
| P577 | publication date | 2003-05-13 | |
| P1433 | published in | Journal of Cell Science | Q1524177 |
| P1476 | title | CD105 prevents apoptosis in hypoxic endothelial cells | |
| P478 | volume | 116 |
| Q58804683 | A comparison of CD105 and CD31 expression in tumor vessels of hepatocellular carcinoma by tissue microarray and flow cytometry |
| Q28249915 | Abcc6 deficiency causes increased infarct size and apoptosis in a mouse cardiac ischemia-reperfusion model |
| Q33929753 | Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells |
| Q27315862 | Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation |
| Q39094449 | An insert-based enzymatic cell culture system to rapidly and reversibly induce hypoxia: investigations of hypoxia-induced cell damage, protein expression and phosphorylation in neuronal IMR-32 cells. |
| Q39368829 | Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. |
| Q81972050 | Angiogenesis in salivary carcinomas with and without myoepithelial differentiation |
| Q37958949 | Angiogenesis regulation by TGFβ signalling: clues from an inherited vascular disease |
| Q47817290 | Antiapoptotic action of hypoxia-inducible factor-1 alpha in human endothelial cells |
| Q90729566 | Atorvastatin Rejuvenates Neural Stem Cells Injured by Oxygen-Glucose Deprivation and Induces Neuronal Differentiation Through Activating the PI3K/Akt and ERK Pathways |
| Q91666415 | CD105 (Endoglin) as negative prognostic factor in AML |
| Q36041205 | CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma. |
| Q35604414 | CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor β1 (TGF-β1) signaling |
| Q36320615 | CEACAM engagement by human pathogens enhances cell adhesion and counteracts bacteria-induced detachment of epithelial cells |
| Q33828642 | Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration |
| Q40573463 | Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation |
| Q88959857 | Cytotoxic Effects of Nonionic Iodinated Contrast Agent on Human Adipose-Derived Mesenchymal Stem Cells |
| Q46733681 | Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. |
| Q28205813 | EndoPDI, a novel protein-disulfide isomerase-like protein that is preferentially expressed in endothelial cells acts as a stress survival factor |
| Q43121223 | Endoglin - a marker of vascular endothelial cell proliferation in cancer |
| Q47968783 | Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia |
| Q84718191 | Endoglin as a marker in cervical paragangliomas |
| Q33988427 | Endoglin deficiency impairs stroke recovery |
| Q38180309 | Endoglin for targeted cancer treatment |
| Q38074721 | Endoglin for tumor imaging and targeted cancer therapy. |
| Q39401943 | Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies. |
| Q41857049 | Endothelial cell survival during angiogenesis requires the pro-survival protein MCL1 |
| Q36476019 | Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis |
| Q36241043 | Functional significance of CD105-positive cells in papillary renal cell carcinoma. |
| Q34555915 | Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet |
| Q24798737 | Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer |
| Q51443453 | Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. |
| Q28573546 | Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression |
| Q34458617 | Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines. |
| Q24294521 | Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex |
| Q30436395 | Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study |
| Q35572874 | Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia |
| Q33666756 | Maternal and Cord Blood Plasma sEng and TGF-β1 in Patients with Hypertensive Disorders of Pregnancy: A Pilot Study in a South Indian Population |
| Q35089199 | Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression |
| Q52623830 | Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease. |
| Q51615949 | Neuroprotective Effects of Acetyl-L-Carnitine Against Oxygen-Glucose Deprivation-Induced Neural Stem Cell Death. |
| Q36381160 | Novel biochemical pathways of endoglin in vascular cell physiology. |
| Q43235423 | Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells |
| Q52714198 | PATHOGENIC VARIANTS IN THE ABCC6 GENE ARE ASSOCIATED WITH AN INCREASED RISK FOR ISCHEMIC STROKE. |
| Q37022723 | Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction |
| Q37114991 | Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections |
| Q35664735 | Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors |
| Q48425540 | Role of endoglin and transforming growth factor-beta in progressive white matter damage after an ischemic stroke. |
| Q24310560 | S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology |
| Q33650241 | Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia |
| Q34092005 | Stem cell pathways contribute to clinical chemoresistance in ovarian cancer |
| Q37359962 | TGF-beta signaling in vascular biology and dysfunction |
| Q37610628 | Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours |
| Q36300487 | The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis |
| Q37775427 | The physiological role of endoglin in the cardiovascular system. |
| Q92646416 | The role of SOX2 in angiogenesis in breast cancer |
| Q39036151 | The role of endoglin in post-ischemic revascularization. |
| Q46528698 | The roles of endoglin gene in cerebrovascular diseases |
| Q39365796 | Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents. |
| Q37967810 | Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing |
| Q37190206 | Transforming growth factor-beta1 causes pulmonary microvascular endothelial cell apoptosis via ALK5. |
| Q36808007 | Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5. |
| Q35159432 | Unforeseen decreases in dissolved oxygen levels affect tube formation kinetics in collagen gels |
| Q38909867 | Vascular Endothelial Growth Factor Isoform-B Stimulates Neurovascular Repair After Ischemic Stroke by Promoting the Function of Pericytes via Vascular Endothelial Growth Factor Receptor-1. |
Search more.